After over more than 30 years, Good Doctor Pharmaceutical Group Co., Ltd. ("Good Doctor Group") has evolved into a large enterprise group comprehensively developing the "big health" industry, integrating science, manufacturing, and trade with a core focus on biomedicine. The Group's operations span seven major sectors: pharmaceutical manufacturing, pharmaceutical distribution, pharmaceutical R&D, healthcare services, Chinese medicinal material cultivation and breading bases, modern agricultural processing, and comprehensive healthcare. The Group comprises 37 wholly-owned subsidiaries, one internet healthcare platform company, and three medical trading companies. With operations across Sichuan, Yunnan, Shanxi, Liaoning, Guizhou, and other Provinces, the Group employs over 20,000 staff members.
Good Doctor Group adheres to the corporate philosophy of "Doing Good, Making Good Medicine," pursuing innovation-driven development strategies. It has successively established a National Enterprise Technology Center, a Provincial Enterprise Technology Center, the Sichuan Provincial Key Laboratory for Medicinal Periplaneta Americana, and the Sichuan Provincial Engineering Technology Research Center for Medicinal Animals. The Group boasts four High-tech Enterprises and one National Key Leading Enterprise in Agricultural Industrialization. The Group has further established the first provincial-level academician (expert) workstation and national-level postdoctoral research workstation in the Three Prefectures region. Industry-academia-research collaboration has been formed with over 20 domestic universities and research institutions, including Shanghai Jiao Tong University, Zhejiang University, Sichuan University, Macau University of Science and Technology, Chengdu University of TCM, Wenzhou Medical University, Southwest Minzu University, Dali University, and Kunming University of Science and Technology. The Group has undertaken more than 70 national, provincial, and ministerial-level R&D innovation projects.
Good Doctor Group has been listed among the Ministry of Industry and Information Technology's "Top 100 Chinese Pharmaceutical Enterprises" for 14 consecutive years. It ranks among the "Top 100 Chinese TCM Manufacturers,""Top 100 Chinese Patent Medicine Enterprises," and "Top 100 Private Enterprises in Sichuan." The Good Doctor brand holds the titles of "China Well-Known Trademark,""China Famous Brand,""China Pharmaceutical Brand,""Sichuan Famous Brand,""Sichuan Innovative Brand," and "Sichuan Signature Brand."
"Doing Good, Making Good Medicine, Caring for Public Health"—Good Doctor Group always practices its mission. We don't make grand declarations; we simply strive to uphold and practice the most unadorned principles: being conscientious individuals, producing highly effective medicines, and delivering genuine health to the masses. This is our past and current commitment, and will remain our commitment forever!
Rotating President of the China Pharmaceutical Enterprises Association, Vice President of the China Private Economy Research Association, Vice President of the China Association of Traditional Chinese Medicine, Vice President of the Chinese Medicine Education Association, President of the Sichuan Pharmaceutical Industry Association, Vice Chairman of the Sichuan Pharmaceutical Society, Vice President of the Sichuan Glorious Cause Promotion Association, President of Chengdu Liangshan Chamber of Commerce, Chairman of the New Chinese Medicine Development Committee, Chinese Medicine Education Association, President of the Chinese Medicine Clinic Branch, China Folk Medicine Research and Development Association
In 2023, honored as an "Advanced Individual in Rural Revitalization";
In 2022, honored as one of the "Top Ten Economic Influential Figures in Sichuan" and recognized as an "Outstanding Individual in Sichuan Province's 'Ten Thousand Enterprises Revitalizing Ten Thousand Villages' Initiative";
In 2021, honored as an "Outstanding Individual in Poverty Alleviation" by the Central Committee of the Communist Party of China State Council.
In 2020, honored as a "National Advanced Individual in the Fight Against the Pandemic from the Private Sector" by the United Front Work Department of the CPC Central Committee and presented the 11th "China Charity Award" from the Ministry of Civil Affairs;
In 2019, honored as one of the "Top Ten Figures in the Pharmaceutical Industry";
In 2018, presented the "National Poverty Alleviation Award for Dedication" by the State Council Leading Group Office of Poverty Alleviation and Development;
In 2016, awarded the "First Prize for Scientific and Technological Progress of Sichuan Province" and the "First Sichuan Outstanding Talent Award."
Chairman Geng Funan is a leading academic and technical expert in Sichuan Province and a member of the Decision-Making Advisory Committee of the Sichuan Provincial Party Committee and Provincial Government. He serves as a visiting professor at Zhejiang University, Sichuan University, Chengdu University of Traditional Chinese Medicine, and Soochow University. He is the recipient of Tianfu Elite A Card and Sichuan Outstanding Talent Award. He has undertaken multiple national key R&D programs and nearly 100 provincial/ministerial-level research projects. Holding over 100 invention patents, he has received five provincial/ministerial first prizes, and led the development of several Class I new drugs.
In 1986, we embarked on an undertaking—an undertaking dedicated to human health—committed to providing high-quality products for the well-being of the public.
For over 30 years, we have steadfastly adhered to the production philosophy that "product quality reflects character," upholding the corporate ethos of "doing good and making good medicine." We have consistently placed the health interests of the people at the forefront of our corporate development. For we understand that regulations, standards, and rigorous quality management are the very foundation of the pharmaceutical industry.
Building a comprehensive healthcare ecosystem, sharing the benefits of TCM. As members of the Good Doctor Group, we hold ourselves accountable to the name of "Good Doctor." We strive for excellence, embrace innovation, and unite on the Good Doctor platform to forge a brilliant future for Chinese medicine. We firmly believe that this steadfast commitment to the essence of our profession will drive the advancement of medical science and technology, ultimately benefiting all human beings.
In the economic sphere, a strong brand is a company's treasure trove.
The quality of drugs is not inspected out but produced.
All enterprises that attach great importance to social responsibility are bound to grow bigger and stronger. This is my experience. Based on this concept and understanding of ours, it is essential to incorporate social responsibility into the development strategy of the enterprise. This is a fundamental for the enterprise to grow stronger and larger. Corporate social responsibility is not a sudden whim but requires long-term persistence. We will do our utmost to fulfill social responsibilities, serve public health and build a harmonious society.
An industry is water and an enterprise is a fish. When an industry thrives, a company's brand becomes renowned. Cherish the industry as you would cherish your own eyes. Advocate elite competition and build a harmonious industry environment.
©SICHUAN FNY BIOTECHNOLOGY CO., LTD. All Right Reserved.